Samplfy

Company Overview

Snapshot

Founded in July 2020 by Varda Aberbach, Samplfy operates with 1–10 employees. The company is currently in the Pre-Funding stage, focusing on developing its patented solution for urine collection and digital analysis.

Business overview

Samplfy develops a urine and data collection system designed to provide reliable test results for women. The company's core technology includes patented urine collectors that enable hands-free, fluent, and contact-free urine collection, along with applications for digital detection and analysis of information. Samplfy aims to address challenges in current urine collection methods, serving the medical device and digital health sectors, and benefiting patients, healthcare providers, and laboratories by improving sample quality and reducing invalid test results.

Company Intelligence Q&A

What is Samplfy's primary focus?

Samplfy focuses on developing a urine and data collection system for women to improve the accuracy and convenience of urine testing, particularly for conditions like UTIs, STIs, and during pregnancy.

Who founded Samplfy?

Samplfy was founded by Varda Aberbach in July 2020.

What problem does Samplfy aim to solve?

Samplfy aims to solve the problem of challenging and inconvenient urine collection methods for women, which often lead to inaccurate results, repeated tests, and incorrect treatments. The company's solution seeks to reduce invalid culture tests and uncompleted 24-hour urine collection tests.

What is the current stage of Samplfy's product development?

Samplfy's product is currently in the R&D stage, with plans for a second development phase to provide broad innovative urine rapid results.

What types of customers does Samplfy target?

Samplfy targets patients, healthcare providers, and laboratories, with its solutions designed to be used by seniors, people with disabilities or obesity, and children.